panel discussion on 'technology and diseases'
Answers
Explanation:
Panel Discussion - Digital Health Technology is Transforming Healthcare Delivery
October 3, 2019
The 9th Annual U.S.-China Health Summit took place September 26-27, 2019 at the Joseph B. Martin Conference Center at Harvard Medical School (HMS) in Boston, Massachusetts. Over 400 U.S. and Chinese leaders across major health care sectors congregated to address the two themes of more effective investment in healthcare innovation and establishment of sustainable healthcare systems.
At the panel discussion themed Digital Health Technology is Transforming Healthcare Delivery, five panelists from the U.S. and China introduced the availability and evolving trend of digital technology in the field of diagnosis and treatment to the audience.
David Mou, Co-founder and Chief Medical Office, Valera Health; Psychiatrist at Massachusetts General Hospital;
Corey McCann, President and CEO of Pear Therapeutics;
Joseph Kvedar, Vice president, Connected Health, Partners Healthcare; Professor of Harvard Medical School;
Ligang Zhang, Founder, President and CEO of iKang Healthcare Group;
Lingyun Su, Former Senior Director, AliHealth Research Institute.
The discussion began with Dr. Mou’s first question to the guests, namely, how doctors viewed digital health. Dr. Kvedar, who serves as an executive in a hospital, believed that doctors would not rush to endorse a particular healthcare application (APP) when faced with numerous choices. Therefore, a question deserves reflection is how to make clinicians willing to try innovative medical software and how to promote digital medical devices. Mr. McCann added that digital software must have a solid data foundation so that the accuracy of the diagnosis can be improved to make the innovative healthcare more convincing.